Clinical Trials · NCT03757130
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Amgen
- Enrollment
- 50
- Start date
- Nov 2018
- Locations
- 4 sites, United States
- Primary endpoint
- Number of Participants With Treatment-emergent Adverse Events